| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
12,411 |
10,054 |
$2.43M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,342 |
5,088 |
$1.51M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,105 |
8,407 |
$1.47M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,644 |
3,575 |
$356K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,200 |
3,453 |
$344K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,116 |
6,448 |
$327K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,247 |
2,356 |
$284K |
| 71045 |
Radiologic examination, chest; single view |
6,369 |
4,967 |
$250K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,794 |
2,159 |
$244K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,810 |
1,540 |
$231K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,675 |
2,158 |
$210K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
756 |
629 |
$193K |
| G0378 |
Hospital observation service, per hour |
438 |
331 |
$175K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,550 |
4,255 |
$126K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,169 |
480 |
$119K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
771 |
620 |
$114K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,782 |
3,308 |
$112K |
| 93041 |
|
4,264 |
3,420 |
$108K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
8,827 |
7,432 |
$105K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,931 |
2,132 |
$97K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,068 |
6,801 |
$96K |
| 80053 |
Comprehensive metabolic panel |
11,209 |
8,219 |
$89K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,598 |
2,117 |
$83K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,355 |
9,578 |
$65K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,118 |
218 |
$58K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,115 |
794 |
$58K |
| 71046 |
Radiologic examination, chest; 2 views |
1,257 |
1,005 |
$52K |
| 83880 |
|
2,280 |
1,595 |
$43K |
| 80306 |
|
3,254 |
2,611 |
$35K |
| 36415 |
Collection of venous blood by venipuncture |
15,358 |
10,889 |
$35K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
1,363 |
1,157 |
$34K |
| 94799 |
|
1,089 |
866 |
$33K |
| 84484 |
|
4,935 |
3,361 |
$30K |
| 81025 |
|
3,912 |
3,256 |
$26K |
| 51702 |
|
549 |
453 |
$25K |
| 81001 |
|
9,579 |
7,616 |
$22K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,012 |
689 |
$18K |
| 36600 |
|
427 |
285 |
$17K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
638 |
551 |
$17K |
| 74018 |
|
374 |
289 |
$15K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
424 |
280 |
$15K |
| 87420 |
|
1,208 |
1,035 |
$14K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
285 |
246 |
$14K |
| 82553 |
|
1,695 |
1,215 |
$11K |
| 73560 |
|
247 |
187 |
$10K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
116 |
91 |
$10K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,649 |
1,149 |
$9K |
| 82550 |
|
1,894 |
1,364 |
$8K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,494 |
1,693 |
$8K |
| 83735 |
|
2,265 |
1,761 |
$8K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,509 |
2,752 |
$8K |
| 83874 |
|
919 |
650 |
$7K |
| 83605 |
|
1,138 |
793 |
$7K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
319 |
291 |
$7K |
| 83690 |
|
1,379 |
1,074 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,051 |
811 |
$6K |
| 82803 |
|
438 |
287 |
$6K |
| 85379 |
|
838 |
641 |
$5K |
| 73630 |
|
77 |
64 |
$4K |
| 87040 |
|
740 |
373 |
$4K |
| 94664 |
|
1,284 |
919 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,201 |
2,451 |
$4K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
22 |
13 |
$4K |
| 73610 |
|
66 |
56 |
$3K |
| 11721 |
|
167 |
134 |
$3K |
| 36416 |
|
969 |
801 |
$3K |
| 82150 |
|
690 |
543 |
$3K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
41 |
38 |
$3K |
| 73030 |
|
78 |
64 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
542 |
418 |
$3K |
| 80061 |
Lipid panel |
305 |
303 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
207 |
200 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
58 |
52 |
$2K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
13 |
12 |
$1K |
| 96376 |
|
186 |
112 |
$1K |
| 99221 |
|
89 |
81 |
$1K |
| 73130 |
|
22 |
13 |
$1K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
87 |
64 |
$893.88 |
| 99239 |
Hospital discharge day management, more than 30 minutes |
49 |
46 |
$798.52 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
256 |
165 |
$735.59 |
| 85610 |
|
352 |
250 |
$732.18 |
| 85730 |
|
250 |
172 |
$719.55 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
639 |
541 |
$683.55 |
| 71250 |
|
13 |
12 |
$639.44 |
| 87400 |
|
63 |
32 |
$632.19 |
| 01992 |
|
30 |
15 |
$605.15 |
| J3490 |
Unclassified drugs |
649 |
419 |
$547.48 |
| 86677 |
|
51 |
41 |
$473.15 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
1,290 |
640 |
$421.42 |
| 87430 |
|
32 |
30 |
$409.66 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
69 |
24 |
$400.66 |
| 84703 |
|
55 |
50 |
$397.25 |
| 84520 |
|
99 |
80 |
$386.72 |
| 82565 |
|
98 |
79 |
$277.78 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
20 |
14 |
$265.26 |
| 87070 |
|
13 |
12 |
$264.52 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
16 |
16 |
$238.42 |
| 84439 |
|
27 |
27 |
$228.15 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
627 |
426 |
$169.88 |
| J1815 |
Injection, insulin, per 5 units |
126 |
42 |
$144.37 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
75 |
40 |
$77.71 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
475 |
393 |
$59.57 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
42 |
37 |
$53.89 |
| 82607 |
|
13 |
13 |
$47.04 |
| J7510 |
Prednisolone oral, per 5 mg |
502 |
453 |
$36.26 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
14 |
12 |
$28.00 |
| 80320 |
|
62 |
45 |
$23.30 |
| J2780 |
Injection, ranitidine hydrochloride, 25 mg |
33 |
25 |
$18.01 |
| 90715 |
|
44 |
40 |
$17.84 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
16 |
15 |
$15.84 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
108 |
64 |
$11.80 |
| 81015 |
|
16 |
13 |
$8.25 |
| J1940 |
Injection, furosemide, up to 20 mg |
29 |
12 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
111 |
94 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
68 |
46 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
32 |
29 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
22 |
14 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
16 |
12 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
14 |
12 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
20 |
13 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
23 |
15 |
$0.00 |